v3.26.1
RESEARCH AGREEMENTS AND COMMITMENTS (Details)
1 Months Ended 3 Months Ended
Feb. 28, 2026
Jun. 30, 2024
USD ($)
Jun. 30, 2024
EUR (€)
Nov. 30, 2020
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Aug. 31, 2024
USD ($)
Dec. 31, 2022
USD ($)
Jun. 30, 2022
USD ($)
May 31, 2022
USD ($)
Nov. 30, 2021
USD ($)
RESEARCH AGREEMENTS AND COMMITMENTS                      
Research and development         $ 3,433,762 $ 2,374,139          
Therapeutics Inc.                      
RESEARCH AGREEMENTS AND COMMITMENTS                      
Initial term       3 years              
Written termination notice period       90 days              
Total amount of agreement             $ 3,600,000 $ 830,000 $ 4,400,000    
Research and development         1,100,000 411,000          
Netherton Syndrome                      
RESEARCH AGREEMENTS AND COMMITMENTS                      
Total amount of agreement                     $ 250,000
Scleroderma                      
RESEARCH AGREEMENTS AND COMMITMENTS                      
Total amount of agreement                   $ 610,000  
The School of Pharmacy at UCC                      
RESEARCH AGREEMENTS AND COMMITMENTS                      
Research and development         0 $ 60,000          
Maximum funding amount   $ 655,000 € 567,000                
Commitment period   2 years 6 months 2 years 6 months                
Evestia Clinical Limited                      
RESEARCH AGREEMENTS AND COMMITMENTS                      
Initial term 5 years                    
Written termination notice period 30 days                    
Total amount of agreement         800,000            
Research and development         $ 64,000